Two dead, four hospitalized after stool transplants
Two people died after receiving therapeutic stool transplants, according to the FDA, raising alarm about the newfangled approach to treating certain bacterial infections.
As STAT’s Kate Sheridan reports, in addition to the two deaths, four patients were hospitalized and two more may have been affected by transplants from three donors whose stool contained illness-causing bacteria. The transplants came from OpenBiome, a Cambridge, Mass., stool bank whose products are used to treat recurrent C. difficile infections by implanting helpful bacteria.
The latest concern is less than a year removed from a case in which two patients died after receiving stool transplants. And it comes just as companies developing manufactured versions of microbiome-based therapies are gaining steam.
Read more.
As STAT’s Kate Sheridan reports, in addition to the two deaths, four patients were hospitalized and two more may have been affected by transplants from three donors whose stool contained illness-causing bacteria. The transplants came from OpenBiome, a Cambridge, Mass., stool bank whose products are used to treat recurrent C. difficile infections by implanting helpful bacteria.
The latest concern is less than a year removed from a case in which two patients died after receiving stool transplants. And it comes just as companies developing manufactured versions of microbiome-based therapies are gaining steam.
Read more.
.png)
No hay comentarios:
Publicar un comentario